Teknova Reports First Quarter 2024 Financial Results
May 13, 2024 16:01 ET
|
Alpha Teknova, Inc.
First quarter 2024 total revenue was $9.3 million, up 2% from prior yearLaunch of Build-Tek™ Custom ConfiguratorCompany reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., May 13,...
Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development
May 07, 2024 10:00 ET
|
Alpha Teknova, Inc.
First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use in early-stage experiments, all with exceptionally...
Teknova to Report First Quarter 2024 Financial Results on May 13, 2024
April 29, 2024 16:01 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of...
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
March 11, 2024 16:01 ET
|
Alpha Teknova, Inc.
Full year 2023 total revenue was $36.7 million, down 11% year-over-yearAchieved 36% annual growth in the number of Clinical Solutions customers in 2023Company provides 2024 revenue guidance of $35-38...
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
February 21, 2024 16:01 ET
|
Alpha Teknova, Inc.
Teknova announces plans to issue fourth quarter and full year 2023 earnings report on March 11, 2024.
Teknova Reports Third Quarter 2023 Financial Results
November 09, 2023 16:01 ET
|
Alpha Teknova, Inc.
Teknova today announced financial results for the third quarter ended September 30, 2023.
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
October 26, 2023 08:00 ET
|
Alpha Teknova, Inc.
Teknova today announced that the Company will report its financial results for the third quarter on Thursday, November 9, 2023, following close of market.
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
September 27, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
September 19, 2023 16:01 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
September 18, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...